Pandial, Florendina .

HRN: 02-96-85  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2026
CEFTRIAXONE 1G (VIAL)
04/23/2026
04/30/2026
IV
2g
OD
UTI
Checking Initial Appropriateness 
04/26/2026
ACICLOVIR 400MG (TAB)
04/26/2026
05/03/2026
PO
400mg
OD
Multiple Myeloma In Relapse
Checking Initial Appropriateness 
05/01/2026
ACICLOVIR 400MG (TAB)
05/01/2026
05/07/2026
PO
400mg
OD
Multiple Myeloma In Relapse
Checking Initial Appropriateness 
05/01/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/01/2026
05/08/2026
IV
1000mg
1hr Infusion OD
Non Resolving Pneumonia (ESBL E Cloacae)
Checking Initial Appropriateness 
05/03/2026
ACICLOVIR 400MG (TAB)
05/03/2026
05/09/2026
PO
400mg
OD
Multiple Myeloma
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: